Richard B. Mertens, MD, PhD
Senior Surgical Pathologist
Education and Training
- University of California, San Diego, CA; MD, Ph.D.
- Residency in Anatomic Pathology and Clinical Pathology, University of Washington Affiliated Hospitals, Seattle, WA
- Fellowship in Anatomic Pathology, Cedars-Sinai Medical Center, Los Angeles, CA
Medical Board Certifications
- Board Certified, Anatomic Pathology
- Board Certified, Clinical Pathology
Clinical and Research Interests
- Gastrointestinal and Pancreatic Pathology
- Breast Pathology
Awards and Activities
- CAP Pathologist Spotlight Service Award, College of American Pathologists
- Golden Apple Awards for Excellence in Teaching
- Member, Colorectal Cancer Center of Excellence, Cedars-Sinai Medical Center
- Member, Samuel Oschin Comprehensive Cancer Institute
- J Koo, RB Mertens, JM Mirocha, HL Wang, D Dhall. Value of Islet 1 and PAX-8 in identifying metastatic neuroendocrine tumors of pancreatic origin. Modern Pathol 2012;25:893-901.
- Dhall, Mertens R, Bresee C, Parakh R, et al. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiation ileal neuroendocrine tumors. Human Pathol 2012;43:489-95.
- Fan L, Levy M, Aguilar CE, Mertens RB, Dhall D, Frishberg, Wang HL. Lymph node retrieval from colorectal resection specimens for invasive adenocarcinoma: Is it worth the extra effort to find at least 12 nodes? Colorectal Disease 2011;13: 1377-83.
Click here for a list of peer-reviewed publications by Richard Mertens, MD, PhD